NANTES, France, February 26, 2026 – 6pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced that the Independent ...
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...
Since climate change and global warming are wreaking havoc, exposure to climate risk insights is vital because it helps in the right course of action. As a result, Informatica Intelligent Data ...
AB Science reports positive IDMC recommendation to continue the study based on a trend analysis of the masitinib phase 2/3 study in refractory metastatic colorectal cancer AB Science SA (NYSE Euronext ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...
The IDMC conducted an in-depth evaluation of interim safety data from 89 enrolled patients and found no significant safety concerns that would impact the trial's continuation. To date, Daewoong has ...
Informatica has long been a dominant force in enterprise data management. But the landscape is changing. Learn how its shift to cloud-only impacts its viability as a test data management tool.
Shares of Regeneron Pharmaceuticals Inc. slumped 1.2% in morning trading Friday, after the biotechnology company said an independent data monitoring committee (IDMC) for the REGN-COV2 antibody ...
PharmaMar (MSE:PHM) has announced today that the Independent Data Monitoring Committee (IDMC) has notified the Company of its recommendation that the Phase III (ATLANTIS) trial currently under way ...
A record 75.9 million people are living in internal displacement due to conflict, and nearly half that number is in sub-Saharan Africa, according to a recent report. The report from the Internal ...
Theorem Clinical Research Advances IDMC/DSMB and CEC Management Services with New Associate Director
(King of Prussia, PA; September 19, 2012) – Theorem Clinical Research Inc., a full-service contract research organization (CRO) that provides core clinical research and development services, continues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results